The short-term administration of Ketoprofen does not decrease the effect of Pleurodesis induced by talc or...

Area of Science:

• Medical research
• Pharmacology
• Pulmonology

Background:

• Pleurodesis is a medical procedure to treat conditions like malignant pleural effusion.
• Talc and doxycycline are commonly used sclerosing agents for pleurodesis.
• Non-steroidal anti-inflammatory drugs (NSAIDs) are often used for pain management, raising questions about their interaction with pleurodesis.

Purpose of the Study:

• To investigate the effect of ketoprofen, an NSAID, on pleurodesis efficacy.
• To determine if concomitant administration of ketoprofen alters the outcomes of talc or doxycycline-induced pleurodesis in a rabbit model.

Main Methods:

• New Zealand rabbits were divided into four groups, receiving talc or doxycycline intrapleurally, with or without concurrent ketoprofen administration.
• Ketoprofen was administered intramuscularly starting 4 hours before sclerosing agents and continued twice daily for one week.
• Pleural fluid analysis and macroscopic/microscopic evaluation of pleurodesis were performed at specific time points.

Main Results:

• Ketoprofen administration did not significantly alter white blood cell count, LDH, or protein levels in pleural fluid at 24 hours.
• No significant differences were observed in macroscopic pleurodesis scores, pleural fibrosis, pleural thickness, or angiogenesis between groups.

Conclusions:

• Short-term systemic administration of NSAIDs, specifically ketoprofen, does not compromise the efficacy of talc or doxycycline-induced pleurodesis in rabbits.
• These findings suggest that NSAIDs can be safely used in conjunction with these pleurodesis agents without affecting the procedure's success.